Clinical Trials Logo

Filter by:
NCT ID: NCT01649115 Not yet recruiting - Childhood Obesity Clinical Trials

The Healthy Lifestyles Passport Program: a Nutrition Education Program to Prevent Childhood Obesity

HLPP
Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of the Healthy Lifestyles Passport Program (HLPP) in preventing infant and childhood obesity. It is hypothesized that the participants in the intervention arm will exhibit less excessive weight-for-length gain from 4- to 6-months of age. In 2-years and 5-years, it is predicted that the participants in the intervention arm will yield lower Body Mass Index (BMI) z-scores than the participants in the control arm, who receive usual care.

NCT ID: NCT01641887 Not yet recruiting - Esophageal Cancer Clinical Trials

Decision Aid for Gastroesophageal Reflux Disease Management

Start date: January 2014
Phase: N/A
Study type: Observational

The study is to test a decision aid that is designed to help patients make decision regarding management of their gastroesophageal reflux disease (GERD). Once the decision aid is constructed we will test and assess the aid on ~100 patients who have GERD to assess effectiveness.

NCT ID: NCT01626105 Not yet recruiting - Hemophilia A Clinical Trials

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

PPTIH
Start date: June 2012
Phase: N/A
Study type: Observational

This study is designed to accurately identify the pharmacogenetic determinants of risk of Factor VIII (FVIII) inhibitor development by focusing on only a select group of Hemophilia A (HA) patients who have: (i) received a recombinant FVIII therapeutic product containing the same primary amino acid sequence since their original diagnosis; (ii) verifiable FVIII infusion histories; and (iii) been tested regularly for FVIII inhibitor development.

NCT ID: NCT01616589 Not yet recruiting - Fragile X Syndrome Clinical Trials

Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay

Start date: July 2012
Phase: N/A
Study type: Observational

The purpose of this research is to determine if saliva samples can be used as an alternate sample type to test for fragile X. By using saliva instead of blood, it would be easier for patients to have fragile X testing.

NCT ID: NCT01606527 Not yet recruiting - Clinical trials for Spectrum of Altitude-associated Neurologic Forms of Altitude

NSAID RCT for Prevention of Altitude Sickness

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The proposed study is a prospective, randomized, double-blind, placebo-controlled clinical trial evaluating ibuprofen and placebo for the prevention of neurological forms of altitude illness [including high altitude headache (HAH), acute mountain sickness (AMS), high altitude cerebral edema (HACE), and an emerging concept of High Altitude Anxiety]. The study will take place in the spring and summer of 2012 at the Marine Corps Mountain Warfare Training Center in the Eastern Sierras near Bridgeport, California. US Marines from near sea level will participate in battalion-level training exercises at between 8,500-11,500 Feet, where some altitude illness is expected. Concurrent measures used to determine objective markers of altitude illness, such that validated clinical scales, rapid cognitive screening tests, will inform us of symptoms of altitude illness.

NCT ID: NCT01591525 Not yet recruiting - Diabetes Mellitus Clinical Trials

Diabetes Mellitus Community Based Screening in Minority Populations

Start date: June 2012
Phase: N/A
Study type: Observational

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as help patients without a regular primary care physician (PCP) find one within their community. These goals will be achieved first through a glucose measurement. Individuals with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test. The HgA1c test will tell us about the patients average blood sugar over the past 3 months, which will allow us to immediately diagnose new and uncontrolled type II diabetics. All participants will fill out a survey on healthcare seeking behaviors before glucose testing. All patients who enter the study will receive education on T2D and the value of regularly visiting their PCP, and will be provided a list of PCP currently accepting new patients within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the success this community based screening. The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.

NCT ID: NCT01589640 Not yet recruiting - Dry Eye Clinical Trials

Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance

Start date: May 2012
Phase: Phase 4
Study type: Observational

This is a single center clinical study designed to determine patient satisfaction and the effect of the use of artificial tears on tear osmolarity with time after instillation of three commercially available artifical tear eye solutions ( Blink Tears, Blink Gel Tears and Systane Balance).

NCT ID: NCT01569555 Not yet recruiting - Pathology Clinical Trials

Significant Pathology Associated With Crossed Leg Sign

Start date: May 2012
Phase: N/A
Study type: Observational

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

NCT ID: NCT01569542 Not yet recruiting - Pathology Clinical Trials

Crossed Leg Sign and it's Correlation With Significant Pathology

Start date: May 2012
Phase: N/A
Study type: Observational

By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

NCT ID: NCT01566916 Not yet recruiting - Clinical trials for Total Hip Arthroplasty

Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem

Start date: n/a
Phase: N/A
Study type: Interventional

This prospective, randomized study will study the 2 year survivorship and short term outcomes of a currently-used femoral stem: the Bone Preservation Tri-Lock femoral stem using two surgical approaches. The surgical approaches being studied are direct anterior and anterolateral. Implant survivorship, radiographic positioning, and functional outcomes will be compared. Subjects will be randomized to surgical approach and followed for a period of two years.